SCHEMBL17616523

SCHEMBL17616523

Cn1nc(O)c2c(Cl)ccc(C(C)(C)C)c21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16154712 0.82 MAPK8 (0.33) —
SCHEMBL16154723 0.81 HTT (0.33) —
SCHEMBL19788834 0.78 — —
SCHEMBL17621278 0.78 MEN1 (0.31) —
SCHEMBL17761167 0.77 — —
SCHEMBL17544386 0.77 PIK3CD (0.30) —
SCHEMBL20079064 0.76 ALDH1A1 (0.41) —
SCHEMBL19788773 0.75 CRHR1 (0.34) —
SCHEMBL20079063 0.75 — —
SCHEMBL19788778 0.75 CDK8 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9873680-B2 Therapeutic compounds GILEAD SCIENCES, INC. (US) 2018-01-23 — — US disclosed
US-9873680-B2 Therapeutic compounds GILEAD SCIENCES, INC. (US) 2018-01-23 — — US disclosed
US-20160083368-A1 THERAPEUTIC COMPOUNDS GILEAD SCIENCES, INC. 2016-03-24 — — US disclosed
Send feedback